https://www.selleckchem.com/products/OSI-906.html
Of these 40 recommendations for efficacy trials, 35 (88%) were considered supportive of individualized dosing. Eighteen of these 40 recommendations (45%) were incorporated into efficacy trials and 11 (28%) were incorporated into labeling. This research suggests that early FDA-sponsor interactions can support the study of doses in efficacy trials that may lead to individualized dosing strategies in labeling. Proactive Health Support is a telephone-based self-management intervention that is carried out in Denmark by Registered Nurses who
Like
Comment
Share
